目次

Table of Contents

Chapter 1 Report Scope and Objectives
1.1 Market Segmentation and Scope
1.1.1 Segment Definitions
1.1.1.1 Treatment segment
1.1.1.2 Product segment
1.2 Regional Scope
1.3 Estimates and Forecast Timeline
1.4 Objectives
1.4.1 Objective - 1
1.4.2 Objective - 2
1.4.3 Objective - 3
1.5 Research Methodology
1.6 Information Procurement
1.6.1 Purchased Database
1.6.2 GVR’s Internal Database
1.6.3 Secondary Sources
1.6.4 Primary research
1.7 Information or Data Analysis
1.7.1 Data Analysis Models
1.8 Market Formulation & Validation
1.9 Model Details
1.9.1 Commodity Flow Analysis
1.10 List of Secondary Sources
1.11 List of Abbreviations

Chapter 2 Executive Summary
2.1 Market Outlook
2.2 Segment Outlook
2.2.1 Treatment
2.2.2 Product
2.2.5 Region
2.3 Competitive Insights

Chapter 3 Market Variables, Trends & Scope
3.1 Market Lineage Outlook
3.2 Narcolepsy Therapeutics Market Dynamics
3.2.1 Market Driver Analysis
3.2.1.1 Increasing global prevalence of narcolepsy
3.2.1.2 Narcolepsy awareness programs and services
3.2.1.3 Presence of reimbursement policies regarding narcolepsy
3.2.2 Market Restraint Analysis
3.2.2.1 Adverse effects and risks related to narcolepsy drugs
3.2.2.2 Delayed diagnosis or misdiagnosis
3.3 Narcolepsy Therapeutics Market: Business Environment Analysis Tools
3.3.1 Porter's Five Forces Analysis
3.3.1.1 Threat of new entrants
3.3.1.2 Bargaining power of suppliers
3.3.1.3 Bargaining power of buyers
3.3.1.4 Competitive rivalry
3.3.1.5 Threat of Substitutes
3.3.2 PESTEL Analysis
3.3.2.1 Political & Legal
3.3.2.2 Economic & Social
3.3.2.3 Technological
3.4 Penetration & Growth Prospect Mapping
3.5 Impact of COVID-19 on the narcolepsy therapeutics market

Chapter 4 Narcolepsy Therapeutics Market: Treatment Analysis
4.1 Narcolepsy Therapeutics Component Market Share Analysis, 2022 & 2030
4.2 Narcolepsy Therapeutics Component Market: Segment Dashboard:
4.3 Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Treatment Segment
4.3.1 Narcolepsy with Cataplexy
4.3.1.1 Narcolepsy with cataplexy market, 2018 - 2030 (USD Million)
4.3.2 Narcolepsy without Cataplexy
4.3.2.1 Narcolepsy without cataplexy market, 2018 - 2030 (USD Million)
4.3.3 Secondary Narcolepsy
4.3.3.1 Secondary narcolepsy market, 2018 - 2030 (USD Million)

Chapter 5 Narcolepsy Therapeutics Market: Product Mode Analysis
5.1 Narcolepsy Therapeutics Product Mode Market Share Analysis, 2022 & 2030
5.2 Narcolepsy Therapeutics Product Mode Market: Segment Dashboard
5.3 Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Product Mode Segment
5.3.1 Central Nervous System Stimulants
5.3.1.1 Central nervous system stimulants market, 2018 - 2030 (USD Million)
5.3.2 Sodium Oxybate
5.3.2.1 Sodium oxybate market, 2018 - 2030 (USD Million)
5.3.3 Selective Serotonin Reuptake Inhibitor (SSRI)
5.3.3.1 Selective Serotonin Reuptake Inhibitor (SSRI) market, 2018 - 2030 (USD Million)
5.3.4 Tricyclic antidepressants
5.3.4.1 Tricyclic antidepressants market, 2018 - 2030 (USD Million)
5.3.5 Other Narcolepsy Drugs
5.3.5.1 Others market, 2018 - 2030 (USD Million)

Chapter 6 Narcolepsy Therapeutics Market: Regional Analysis
6.1 Narcolepsy Therapeutics Regional Market Share Analysis, 2022 & 2030
6.2 Regional Market Snapshot
6.2. North America
6.2.1. SWOT Analysis
6.2.2. North America Narcolepsy Therapeutic Market, 2018 - 2030 (USD Million)
6.2.3. U.S.
6.2.3.1. Key Country Dynamics
6.2.3.2. Target Disease Prevalence
6.2.3.3. Competitive Scenario
6.2.3.4. Regulatory Framework
6.2.3.5. U.S. Narcolepsy Therapeutic Market, 2018 - 2030 (USD Million)
6.2.4. Canada
6.2.4.1. Key Country Dynamics
6.2.4.2. Target Disease Prevalence
6.2.4.3. Competitive Scenario
6.2.4.4. Regulatory Framework
6.2.4.5. Canada Narcolepsy Therapeutic Market, 2018 - 2030 (USD Million)
6.3. Europe
6.3.1. SWOT Analysis
6.3.2. Europe Narcolepsy Therapeutic Market, 2018 - 2030 (USD Million)
6.3.3. UK
6.3.3.1. Key Country Dynamics
6.3.3.2. Target Disease Prevalence
6.3.3.3. Competitive Scenario
6.3.3.4. Regulatory Framework
6.3.3.5. UK Narcolepsy Therapeutic Market, 2018 - 2030 (USD Million)
6.3.4. Germany
6.3.4.1. Key Country Dynamics
6.3.4.2. Target Disease Prevalence
6.3.4.3. Competitive Scenario
6.3.4.4. Regulatory Framework
6.3.4.5. Germany Narcolepsy Therapeutic Market, 2018 - 2030 (USD Million)
6.3.5. France
6.3.5.1. Key Country Dynamics
6.3.5.2. Target Disease Prevalence
6.3.5.3. Competitive Scenario
6.3.5.4. Regulatory Framework
6.3.5.5. France Narcolepsy Therapeutic Market, 2018 - 2030 (USD Million)
6.3.6. Italy
6.3.6.1. Key Country Dynamics
6.3.6.2. Target Disease Prevalence
6.3.6.3. Competitive Scenario
6.3.6.4. Regulatory Framework
6.3.6.5. Italy Narcolepsy Therapeutic Market, 2018 - 2030 (USD Million)
6.3.7. Spain
6.3.7.1. Key Country Dynamics
6.3.7.2. Target Disease Prevalence
6.3.7.3. Competitive Scenario
6.3.7.4. Regulatory Framework
6.3.7.5. Spain Narcolepsy Therapeutic Market, 2018 - 2030 (USD Million)
6.3.8. Denmark
6.3.8.1. Key Country Dynamics
6.3.8.2. Target Disease Prevalence
6.3.8.3. Competitive Scenario
6.3.8.4. Regulatory Framework
6.3.8.5. Denmark Narcolepsy Therapeutic Market, 2018 - 2030 (USD Million)
6.3.9. Sweden
6.3.9.1. Key Country Dynamics
6.3.9.2. Target Disease Prevalence
6.3.9.3. Competitive Scenario
6.3.9.4. Regulatory Framework
6.3.9.5. Sweden Narcolepsy Therapeutic Market, 2018 - 2030 (USD Million)
6.3.10. Norway
6.3.10.1. Key Country Dynamics
6.3.10.2. Target Disease Prevalence
6.3.10.3. Competitive Scenario
6.3.10.4. Regulatory Framework
6.3.10.5. Norway Narcolepsy Therapeutic Market, 2018 - 2030 (USD Million)
6.4. Asia Pacific
6.4.1. SWOT Analysis
6.4.2. Asia Pacific Narcolepsy Therapeutic Market, 2018 - 2030 (USD Million)
6.4.3. Japan
6.4.3.1. Key Country Dynamics
6.4.3.2. Target Disease Prevalence
6.4.3.3. Competitive Scenario
6.4.3.4. Regulatory Framework
6.4.3.5. Japan Narcolepsy Therapeutic Market, 2018 - 2030 (USD Million)
6.4.4. China
6.4.4.1. Key Country Dynamics
6.4.4.2. Target Disease Prevalence
6.4.4.3. Competitive Scenario
6.4.4.4. Regulatory Framework
6.4.4.5. China Narcolepsy Therapeutic Market, 2018 - 2030 (USD Million)
6.4.5. India
6.4.5.1. Key Country Dynamics
6.4.5.2. Target Disease Prevalence
6.4.5.3. Competitive Scenario
6.4.5.4. Regulatory Framework
6.4.5.5. India Narcolepsy Therapeutic Market, 2018 - 2030 (USD Million)
6.4.6. Australia
6.4.6.1. Key Country Dynamics
6.4.6.2. Target Disease Prevalence
6.4.6.3. Competitive Scenario
6.4.6.4. Regulatory Framework
6.4.6.5. Australia Narcolepsy Therapeutic Market, 2018 - 2030 (USD Million)
6.4.7. Thailand
6.4.7.1. Key Country Dynamics
6.4.7.2. Target Disease Prevalence
6.4.7.3. Competitive Scenario
6.4.7.4. Regulatory Framework
6.4.7.5. Thailand Narcolepsy Therapeutic Market, 2018 - 2030 (USD Million)
6.4.8. South Korea
6.4.8.1. Key Country Dynamics
6.4.8.2. Target Disease Prevalence
6.4.8.3. Competitive Scenario
6.4.8.4. Regulatory Framework
6.4.8.5. South Korea Narcolepsy Therapeutic Market, 2018 - 2030 (USD Million)
6.5. Latin America
6.5.1. SWOT Analysis
6.5.2. Latin America Narcolepsy Therapeutic Market, 2018 - 2030 (USD Million)
6.5.3. Brazil
6.5.3.1. Key Country Dynamics
6.5.3.2. Target Disease Prevalence
6.5.3.3. Competitive Scenario
6.5.3.4. Regulatory Framework
6.5.3.5. Brazil Narcolepsy Therapeutic Market, 2018 - 2030 (USD Million)
6.5.4. Mexico
6.5.4.1. Key Country Dynamics
6.5.4.2. Target Disease Prevalence
6.5.4.3. Competitive Scenario
6.5.4.4. Regulatory Framework
6.5.4.5. Mexico Narcolepsy Therapeutic Market, 2018 - 2030 (USD Million)
6.5.5. Argentina
6.5.5.1. Key Country Dynamics
6.5.5.2. Target Disease Prevalence
6.5.5.3. Competitive Scenario
6.5.5.4. Regulatory Framework
6.5.5.5. Argentina Narcolepsy Therapeutic Market, 2018 - 2030 (USD Million)
6.6. MEA
6.6.1. SWOT Analysis
6.6.2. MEA Narcolepsy Therapeutic Market, 2018 - 2030 (USD Million)
6.6.3. South Africa
6.6.3.1. Key Country Dynamics
6.6.3.2. Target Disease Prevalence
6.6.3.3. Competitive Scenario
6.6.3.4. Regulatory Framework
6.6.3.5. South Africa Narcolepsy Therapeutic Market, 2018 - 2030 (USD Million)
6.6.4. Saudi Arabia
6.6.4.1. Key Country Dynamics
6.6.4.2. Target Disease Prevalence
6.6.4.3. Competitive Scenario
6.6.4.4. Regulatory Framework
6.6.4.5. Saudi Arabia Narcolepsy Therapeutic Market, 2018 - 2030 (USD Million)
6.6.5. UAE
6.6.5.1. Key Country Dynamics
6.6.5.2. Target Disease Prevalence
6.6.5.3. Competitive Scenario
6.6.5.4. Regulatory Framework
6.6.5.5. UAE Narcolepsy Therapeutic Market, 2018 - 2030 (USD Million)
6.6.6. Kuwait
6.6.6.1. Key Country Dynamics
6.6.6.2. Target Disease Prevalence
6.6.6.3. Competitive Scenario
6.6.6.4. Regulatory Framework
6.6.6.5. Kuwait Narcolepsy Therapeutic Market, 2018 - 2030 (USD Million)

Chapter 7 Competitive Analysis
7.1 Recent Developments & Impact Analysis, By Key Market Participants
7.2 Company Profiles
7.2.1 Teva Pharmaceutical Industries Ltd.
7.2.1.1 Company overview
7.2.1.2 Financial performance
7.2.1.3 Product benchmarking
7.2.1.4 Strategic initiatives
7.2.2 Jazz Pharmaceuticals, Inc.
7.2.2.1 Company overview
7.2.2.2 Financial performance
7.2.2.3 Product benchmarking
7.2.2.4 Strategic initiatives
7.2.3 Harmony Biosciences
7.2.3.1 Company overview
7.2.3.2 Financial performance
7.2.3.3 Product benchmarking
7.2.3.4 Strategic initiatives
7.2.4 Novartis AG
7.2.4.1 Company overview
7.2.4.2 Financial performance
7.2.4.3 Product benchmarking
7.2.4.4 Strategic initiatives
7.2.5 Rhodes Pharmaceuticals L.P.
7.2.5.1 Company overview
7.2.5.2 Financial performance
7.2.5.3 Product benchmarking
7.2.5.4 Strategic initiatives
7.2.6 Janssen Global Services, LLC
7.2.6.1 Company overview
7.2.6.2 Financial performance
7.2.6.3 Product benchmarking
7.2.6.4 Strategic initiatives
7.2.7 Eli Lilly and Company
7.2.7.1 Company overview
7.2.7.2 Financial performance
7.2.7.3 Product benchmarking
7.2.7.4 Strategic initiatives

List of Tables
Table 1 North America narcolepsy therapeutics market, by country, 2018 - 2030 (USD Million)
Table 2 North America narcolepsy therapeutics market, by treatment, 2018 - 2030 (USD Million)
Table 3 North America narcolepsy therapeutics market, by product, 2018 - 2030 (USD Million)
Table 4 U.S. narcolepsy therapeutics market, by treatment, 2018 - 2030 (USD Million)
Table 5 U.S. narcolepsy therapeutics market, by product, 2018 - 2030 (USD Million)
Table 6 Canada narcolepsy therapeutics market, by treatment, 2018 - 2030 (USD Million)
Table 7 Canada narcolepsy therapeutics market, by product, 2018 - 2030 (USD Million)
Table 8 Europe narcolepsy therapeutics market, by country, 2018 - 2030 (USD Million)
Table 9 Europe narcolepsy therapeutics market, by treatment, 2018 - 2030 (USD Million)
Table 10 Europe narcolepsy therapeutics market, by product, 2018 - 2030 (USD Million)
Table 11 UK narcolepsy therapeutics market, by treatment, 2018 - 2030 (USD Million)
Table 12 UK narcolepsy therapeutics market, by product, 2018 - 2030 (USD Million)
Table 13 Germany narcolepsy therapeutics market, by treatment, 2018 - 2030 (USD Million)
Table 14 Germany narcolepsy therapeutics market, by product, 2018 - 2030 (USD Million)
Table 15 France narcolepsy therapeutics market, by treatment, 2018 - 2030 (USD Million)
Table 16 France narcolepsy therapeutics market, by product, 2018 - 2030 (USD Million)
Table 17 Italy narcolepsy therapeutics market, by treatment, 2018 - 2030 (USD Million)
Table 18 Italy narcolepsy therapeutics market, by product, 2018 - 2030 (USD Million)
Table 19 Spain narcolepsy therapeutics market, by treatment, 2018 - 2030 (USD Million)
Table 20 Spain narcolepsy therapeutics market, by product, 2018 - 2030 (USD Million)
Table 21 Denmark narcolepsy therapeutics market, by treatment, 2018 - 2030 (USD Million)
Table 22 Denmark narcolepsy therapeutics market, by product, 2018 - 2030 (USD Million)
Table 23 Sweden narcolepsy therapeutics market, by treatment, 2018 - 2030 (USD Million)
Table 24 Sweden narcolepsy therapeutics market, by product, 2018 - 2030 (USD Million)
Table 25 Norway narcolepsy therapeutics market, by treatment, 2018 - 2030 (USD Million)
Table 26 Norway narcolepsy therapeutics market, by product, 2018 - 2030 (USD Million)
Table 27 Asia Pacific narcolepsy therapeutics market, by country, 2018 - 2030 (USD Million)
Table 28 Asia Pacific narcolepsy therapeutics market, by treatment, 2018 - 2030 (USD Million)
Table 29 Asia Pacific narcolepsy therapeutics market, by product, 2018 - 2030 (USD Million)
Table 30 Japan narcolepsy therapeutics market, by treatment, 2018 - 2030 (USD Million)
Table 31 Japan narcolepsy therapeutics market, by product, 2018 - 2030 (USD Million)
Table 32 China narcolepsy therapeutics market, by treatment, 2018 - 2030 (USD Million)
Table 33 China narcolepsy therapeutics market, by product, 2018 - 2030 (USD Million)
Table 34 India narcolepsy therapeutics market, by treatment, 2018 - 2030 (USD Million)
Table 35 India narcolepsy therapeutics market, by product, 2018 - 2030 (USD Million)
Table 36 Australia narcolepsy therapeutics market, by treatment, 2018 - 2030 (USD Million)
Table 37 Australia narcolepsy therapeutics market, by product, 2018 - 2030 (USD Million)
Table 38 South Korea narcolepsy therapeutics market, by treatment, 2018 - 2030 (USD Million)
Table 39 South Korea narcolepsy therapeutics market, by product, 2018 - 2030 (USD Million)
Table 40 Thailand narcolepsy therapeutics market, by treatment, 2018 - 2030 (USD Million)
Table 41 Thailand narcolepsy therapeutics market, by product, 2018 - 2030 (USD Million)
Table 42 Latin America narcolepsy therapeutics market, by country, 2018 - 2030 (USD Million)
Table 43 Latin America narcolepsy therapeutics market, by treatment, 2018 - 2030 (USD Million)
Table 44 Latin America narcolepsy therapeutics market, by product, 2018 - 2030 (USD Million)
Table 45 Brazil narcolepsy therapeutics market, by treatment, 2018 - 2030 (USD Million)
Table 46 Brazil narcolepsy therapeutics market, by product, 2018 - 2030 (USD Million)
Table 47 Mexico narcolepsy therapeutics market, by treatment, 2018 - 2030 (USD Million)
Table 48 Mexico narcolepsy therapeutics market, by product, 2018 - 2030 (USD Million)
Table 49 Argentina narcolepsy therapeutics market, by treatment, 2018 - 2030 (USD Million)
Table 50 Argentina narcolepsy therapeutics market, by product, 2018 - 2030 (USD Million)
Table 51 MEA narcolepsy therapeutics market, by country, 2018 - 2030 (USD Million)
Table 52 MEA narcolepsy therapeutics market, by treatment, 2018 - 2030 (USD Million)
Table 53 MEA narcolepsy therapeutics market, by product, 2018 - 2030 (USD Million)
Table 54 South Africa narcolepsy therapeutics market, by treatment, 2018 - 2030 (USD Million)
Table 55 South Africa narcolepsy therapeutics market, by product, 2018 - 2030 (USD Million)
Table 56 Saudi Arabia narcolepsy therapeutics market, by treatment, 2018 - 2030 (USD Million)
Table 57 Saudi Arabia narcolepsy therapeutics market, by product, 2018 - 2030 (USD Million)
Table 58 UAE narcolepsy therapeutics market, by treatment, 2018 - 2030 (USD Million)
Table 59 UAE narcolepsy therapeutics market, by product, 2018 - 2030 (USD Million)
Table 60 Kuwait narcolepsy therapeutics market, by treatment, 2018 - 2030 (USD Million)
Table 61 Kuwait narcolepsy therapeutics market, by product, 2018 - 2030 (USD Million)

List of Figures
Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Value chain-based sizing & forecasting
Fig. 4 QFD modeling for market share assessment
Fig. 5 Market Summary, 2022
Fig. 6 Market Trends & Outlook
Fig. 7 Market Segmentation & Scope
Fig. 8 Market driver relevance analysis (Current & future impact)
Fig. 9 Market restrain relevance analysis (Current & future impact)
Fig. 10 SWOT analysis, by factor (political & legal, economic and technological)
Fig. 11 Porter’s Five Forces Analysis
Fig. 12 Narcolepsy therapeutics market type outlook key takeaways
Fig. 13 Narcolepsy therapeutics market: Type movement analysis
Fig. 14 Global narcolepsy with cataplexy market, 2018 - 2030 (USD Million)
Fig. 15 Global narcolepsy without cataplexy market, 2018 - 2030 (USD Million)
Fig. 16 Global secondary narcolepsy market, 2018 - 2030 (USD Million)
Fig. 17 Narcolepsy therapeutics market product outlook key takeaways
Fig. 18 Narcolepsy therapeutics market: Product movement analysis
Fig. 19 Global central nervous system stimulants market, 2018 - 2030 (USD Million)
Fig. 20 Global sodium Oxybate market, 2018 - 2030 (USD Million)
Fig. 21 Global selective serotonin reuptake inhibitor market, 2018 - 2030 (USD Million)
Fig. 22 Global tricyclic antidepressants market, 2018 - 2030 (USD Million)
Fig. 23 Global other narcolepsy drugs market, 2018 - 2030 (USD Million)
Fig. 24 Regional marketplace: Key takeaways
Fig. 25 Regional marketplace: Key takeaways
Fig. 26 North America narcolepsy therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 27 Key country dynamics
Fig. 28 U.S. narcolepsy therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 29 Key country dynamics
Fig. 30 Canada narcolepsy therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 31 Europe narcolepsy therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 32 Key country dynamics
Fig. 33 UK narcolepsy therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 34 Key country dynamics
Fig. 35 Germany narcolepsy therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 36 Key country dynamics
Fig. 37 France narcolepsy therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 38 Key country dynamics
Fig. 39 Spain narcolepsy therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 40 Key country dynamics
Fig. 41 Italy narcolepsy therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 42 Key country dynamics
Fig. 43 Denmark narcolepsy therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 44 Key country dynamics
Fig. 45 Sweden narcolepsy therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 46 Key country dynamics
Fig. 47 Norway narcolepsy therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 48 Rest of Europe narcolepsy therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 49 Asia Pacific narcolepsy therapeutics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 50 Key country dynamics
Fig. 51 Japan narcolepsy therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 52 Key country dynamics
Fig. 53 China narcolepsy therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 54 Key country dynamics
Fig. 55 India narcolepsy therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 56 Key country dynamics
Fig. 57 South Korea narcolepsy therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 58 South Korea reimbursement scenario
Fig. 59 Key country dynamics
Fig. 60 Australia narcolepsy therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 61 Key country dynamics
Fig. 62 Thailand narcolepsy therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 63 Rest of Asia Pacific narcolepsy therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 64 Latin America narcolepsy therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 65 Key country dynamics
Fig. 66 Brazil narcolepsy therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 67 Key country dynamics
Fig. 68 Mexico narcolepsy therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 69 Key country dynamics
Fig. 70 Argentina narcolepsy therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 71 Rest of Latin America narcolepsy therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 72 MEA narcolepsy therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 73 Key country dynamics
Fig. 74 South Africa narcolepsy therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 75 Key country dynamics
Fig. 76 Saudi Arabia narcolepsy therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 77 Key country dynamics
Fig. 78 UAE narcolepsy therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 79 Key country dynamics
Fig. 80 Kuwait narcolepsy therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 81 Rest of MEA narcolepsy therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 82 Key company categorization
Fig. 83 Company categorization
Fig. 84 Company market share analysis, 2022
Fig. 85 Strategic Framework